Literature DB >> 6231206

Rat bladder in the early stages of streptozotocin-induced diabetes: adrenergic and cholinergic innervation.

J Lincoln, M Crockett, A J Haven, G Burnstock.   

Abstract

The adrenergic and cholinergic innervation of the bladder was studied in streptozotocin-diabetic rats. The presence of hypertrophy and distension in the 'diabetic' bladders necessitates care in assessing changes occurring in the nerves, factors which are also relevant to clinical histochemical studies. Biochemical assays of cholinergic enzymes revealed decreased activities per g wet weight tissue. However, the total activities of choline acetyltransferase and acetylcholinesterase per whole bladder were significantly increased after 2 weeks of diabetes with greater changes by 8 weeks. Total dopamine levels per bladder were significantly higher than in control rats in the 2-week but not the 8-week group of animals; this may indicate an initial increase in adrenergic nerve activity. There was no impairment in the ability of the detrusor muscle to respond to noradrenaline, acetylcholine or to cholinergic nerve stimulation. Shortly after induction of diabetes streptozotocin-treated rats display polyuria. It is proposed that the activity of the bladder is therefore stimulated to allow greater volumes of urine to be passed. The results are discussed in relation to human diabetes mellitus where clinical studies have implicated a neuropathic origin to bladder dysfunction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6231206     DOI: 10.1007/bf00252269

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  32 in total

1.  Adrenergic and cholinergic innervation of the rag urinary bladder.

Authors:  P Alm; M Elmér
Journal:  Acta Physiol Scand       Date:  1975-05

2.  Choline acetyltransferase activity in the rat's heart and urinary bladder after chemical sympathectomy.

Authors:  J Ekström
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975-03

3.  A "DIRECT-COLORING" THIOCHOLINE METHOD FOR CHOLINESTERASES.

Authors:  M J KARNOVSKY; L ROOTS
Journal:  J Histochem Cytochem       Date:  1964-03       Impact factor: 2.479

4.  The diabetic bladder.

Authors:  A C Buck; C U McRae; G D Chisholm
Journal:  Proc R Soc Med       Date:  1974-01

5.  The damaged human detrusor: functional and electron microscopic changes in disease.

Authors:  M E Mayo; R W Lloyd-Davies; K E Shuttleworth; J R Tighe
Journal:  Br J Urol       Date:  1973-04

6.  Neurogenic vesical dysfunction and diabetes mellitus.

Authors:  M Kahan; P D Goldberg; E E Mandel
Journal:  N Y State J Med       Date:  1970-10-01

7.  Diagnosis and management of diabetic autonomic neuropathy.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-06

8.  Increase in choline acetyltransferase activity in surgically isolated postganglionic parasympathetic neurones of the urinary bladder of adult rats.

Authors:  J Ekström
Journal:  Acta Physiol Scand       Date:  1981-01

9.  Neurogenic disorders of the bladder in diabetes mellitus. A clinical-roentgenological investigation.

Authors:  O Bartley; I Brolin; S E Fagerberg; L Wilhelmsen
Journal:  Acta Med Scand       Date:  1966-08

10.  Autonomic nervous system and diabetes. Histological and histochemical study of the autonomic nerve fibers of the urinary bladder in diabetic patients.

Authors:  I Faerman; L Glocer; D Celener; M Jadzinsky; D Fox; M Maler; E Alvarez
Journal:  Diabetes       Date:  1973-04       Impact factor: 9.461

View more
  12 in total

1.  Impaired M3 and enhanced M2 muscarinic receptor contractile function in a streptozotocin model of mouse diabetic urinary bladder.

Authors:  K J Pak; R S Ostrom; M Matsui; F J Ehlert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-27       Impact factor: 3.000

2.  Differential effect of guanethidine on dopamine and norepinephrine in rat peripheral tissues.

Authors:  R Favre-Maurice; M De Haut; Y Dalmaz; L Peyrin
Journal:  J Neural Transm Gen Sect       Date:  1992

3.  Inhibitory effect of streptozotocin-induced diabetes on non-cholinergic motor transmission in rat detrusor and its prevention by sorbinil.

Authors:  G N Luheshi; M A Zar
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

4.  The effects of uranyl ions on neuromuscular transmission in the urinary bladder of the normal and streptozotocin-diabetic mouse.

Authors:  S H Liu; S Y Lin-Shiau
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-12       Impact factor: 3.000

5.  Elevated levels of vasoactive intestinal peptide in the eye and urinary bladder of diabetic and prediabetic Chinese hamsters.

Authors:  A R Diani; T Peterson; G A Sawada; B M Wyse; M C Blanks; G C Gerritsen; G Terenghi; I M Varndell; J M Polak; M A Blank
Journal:  Diabetologia       Date:  1985-05       Impact factor: 10.122

6.  Cystometric changes in the early phase of streptozotocin-induced diabetes in rats: evidence for sensory changes not correlated to diabetic neuropathy.

Authors:  P Santicioli; R Gamse; C A Maggi; A Meli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

7.  The effect of streptozotocin-induced diabetes on cholinergic motor transmission in the rat urinary bladder.

Authors:  G N Luheshi; M A Zar
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

8.  Factors underlying the increased sensitivity to field stimulation of urinary bladder strips from streptozotocin-induced diabetic rats.

Authors:  T L Tammela; J A Briscoe; R M Levin; P A Longhurst
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

Review 9.  Purinergic signalling in the urinary tract in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

10.  Changes in the somatostatin, substance P and vasoactive intestinal polypeptide content of the gastrointestinal tract following streptozotocin-induced diabetes in the rat.

Authors:  M Ballmann; J M Conlon
Journal:  Diabetologia       Date:  1985-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.